Category: St. Jude Medical
St. Jude Medical reports 'solid and uncontroversial' preliminary 4th-quarter sales of $1.44 billion despite setbacks with its Portico replacement heart valve.
St. Jude Medical launches a clinical trial to evaluate the use of ablation and cardiac rhythm management devices in treating ventricular tachycardia.
Google Ventures, the VC arm of the Silicon Valley tech monolith, pumped more than ⅓ of its venture spend into healthcare and life science startups during 2014.
Google (NSDQ:GOOG) took a bigger bet on healthcare in 2014, investing more than ⅓ of the its venture dollars in healthcare and life science interests, according to the company and published reports.
Here's a look at some of the top regulatory stories for medical device companies this week: Cianna Medical wins FDA nod for breast surgery device; St. Jude Medical wins CE Mark for Quadra Allure MP pacemaker; Medtronic wins FDA approval for more Attain Performa quad defib leads; FDA postpones panel meeting for VertiFlex's Superion spine device; Report: FDA doesn't disclose most adviser's ties to medtech
Here's a look at some of the top legal news stories for medical device companies this week: CardioKinetix raises $50m, inks buyout deal with Edwards Lifesciences; Angel Medical raises $10m for ischemia devices; Zyga Technology raises $2m; Image Stream Medical looks at $8m
St. Jude Medical says it won CE Mark approval in the European Union for its Quadra Allure MP pacemaker, claiming it as the sole cardiac resynchronization therapy pacemaker to offer multi-point pacing.
Angel Medical Systems, developer of ischemia monitoring devices, is halfway toward raising a planned $20.5 million debt offering.
Angel Medical Systems said it raised about half of a planned $20.5 million debt offering.
The New Jersey-based developer of implantable ischemia monitoring devices said in a regulatory filing that it has pulled in more than $10.2 million so far, with close to $10.29 million yet to be raised.